Arax Advisory Partners

Position in GRFS — Grifols SA

CIK 1586767 DENVER, CO

Position in GRFS

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$569,253

+$245,141 QoQ

Shares Held

80,403

+99.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#53

of 164 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. GRFS ranks #15 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	326,790	$82,994,856
2	MRK	Merck & Co., Inc.	608,608	$78,206,128
3	LLY	ELI LILLY & Co	46,821	$56,158,516
4	ABBV	AbbVie Inc.	164,897	$41,494,681
5	NVO	Novo Nordisk A S	449,006	$21,525,347
6	BMY	Bristol Myers Squibb Co	363,882	$20,966,880
7	PFE	Pfizer Inc	811,104	$19,531,384
8	AMGN	Amgen Inc	50,310	$18,218,257

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$569,253	80,403	+99.0%	Shares	Sole	2026-08-10
2026-03-31	$324,112	40,413	-1.7%	Shares	Sole	2026-05-13
2025-12-31	$384,378	41,110	-65.7%	Shares	Sole	2026-02-13
2025-09-30	$1,193,616	119,841	+205.8%	Shares	Sole	2025-11-14
2025-06-30	$354,232	39,185	0.0%	Shares	Sole	2025-08-12
2025-03-31	$278,605	39,185	0.0%	Shares	Sole	2025-05-15
2024-12-31	$291,536	39,185	0.0%	Shares	Sole	2025-02-05
2024-09-30	$347,962	39,185	0.0%	Shares	Sole	2024-11-06
2024-06-30	$247,257	39,185	0.0%	Shares	Sole	2024-08-06
2024-03-31	$261,755	39,185	+46000.0%	Shares	Sole	2024-05-14
2021-06-30	$1,474	85	—	Shares	Sole	2021-08-02
No filing history on record for this holder in this stock.